These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15528890)

  • 61. Co-infection with three linezolid-resistant Enterococcus faecium ST117 strain variants: what are we missing in diagnosis?
    Freitas AR; Novais C; Read A; Alves V; Peixe L
    Int J Antimicrob Agents; 2016 Jun; 47(6):500-1. PubMed ID: 27179813
    [No Abstract]   [Full Text] [Related]  

  • 62. Tigecycline-based therapy for glycopeptide-resistant Enterococcus faecium infection in a pediatric intensive care unit.
    Trabelsi B; Trifa M; Ben Khalifa S
    Tunis Med; 2016 Jun; 94(6):336-337. PubMed ID: 28051225
    [No Abstract]   [Full Text] [Related]  

  • 63. Human infections caused by glycopeptide-resistant Enterococcus spp: are they a zoonosis?
    Sundsfjord A; Simonsen GS; Courvalin P
    Clin Microbiol Infect; 2001; 7 Suppl 4():16-33. PubMed ID: 11688531
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of enterococcal surface protein gene (esp) and amplified fragment length polymorphism typing of glycopeptide-resistant Enterococcus faecium during its emergence in a Greek intensive care unit.
    Routsi C; Platsouka E; Willems RJ; Bonten MJ; Paniara O; Saroglou G; Roussos C
    J Clin Microbiol; 2003 Dec; 41(12):5742-6. PubMed ID: 14662973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage.
    Bradley SJ; Wilson AL; Allen MC; Sher HA; Goldstone AH; Scott GM
    J Antimicrob Chemother; 1999 Feb; 43(2):261-6. PubMed ID: 11252332
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study of Enterococcus faecium BM6226. A strain resistant to most antibiotics used in enterococcal antibiotherapy.
    Bentorcha F; Delbos F; Horaud T
    Adv Exp Med Biol; 1997; 418():487-9. PubMed ID: 9331700
    [No Abstract]   [Full Text] [Related]  

  • 67. Glycopeptide-resistant Enterococcus faecium outside Hospitals: a commentary.
    Witte W; Klare I
    Microb Drug Resist; 1995; 1(3):259-63. PubMed ID: 9158785
    [No Abstract]   [Full Text] [Related]  

  • 68. Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanB.
    Hayden MK; Picken RN; Sahm DF
    Antimicrob Agents Chemother; 1997 Apr; 41(4):872-4. PubMed ID: 9087511
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of an Enterococcus faecium small-colony variant isolated from blood culture.
    Gröbner S; Beck J; Schaller M; Autenrieth IB; Schulte B
    Int J Med Microbiol; 2012 Jan; 302(1):40-4. PubMed ID: 21968291
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides.
    Klare I; Heier H; Claus H; Witte W
    FEMS Microbiol Lett; 1993 Jan; 106(1):23-9. PubMed ID: 8440464
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diversity and stability of plasmids from glycopeptide-resistant Enterococcus faecium (GRE) isolated from pigs in Denmark.
    Hasman H; Villadsen AG; Aarestrup FM
    Microb Drug Resist; 2005; 11(2):178-84. PubMed ID: 15910234
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glycopeptide-resistant enterococci in Northern Ireland: first reported outbreak.
    Rizkalla EA; Moore JE; Marshall SA; Murphy PG
    J Antimicrob Chemother; 1997 Oct; 40(4):607-8. PubMed ID: 9372439
    [No Abstract]   [Full Text] [Related]  

  • 73. The epidemiology of glycopeptide-resistant enterococci on a haematology unit--analysis by pulsed-field gel electrophoresis.
    Bradley SJ; Kaufmann ME; Happy C; Ghori S; Wilson AL; Scott GM
    Epidemiol Infect; 2002 Aug; 129(1):57-64. PubMed ID: 12211597
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients.
    Ieven M; Vercauteren E; Descheemaeker P; van Laer F; Goossens H
    J Clin Microbiol; 1999 May; 37(5):1436-40. PubMed ID: 10203501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factors associated with acquisition of glycopeptide-resistant enterococci during a single-strain outbreak.
    Deboscker S; Schneider P; Séverac F; Ménard C; Gaudart J; Lavigne T; Meyer N
    Epidemiol Infect; 2019 Jan; 147():e158. PubMed ID: 31063114
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Newer glycopeptide antibiotics tested against nosocomial bloodstream isolates.
    Buschelman BJ; Jones RN
    J Antimicrob Chemother; 1993 Mar; 31(3):445-7. PubMed ID: 8486582
    [No Abstract]   [Full Text] [Related]  

  • 77. Long PCRs of transposons in the structural analysis of genes encoding acquired glycopeptide resistance in enterococci.
    Haaheim H; Dahl KH; Simonsen GS; Olsvik O; Sundsfjord A
    Biotechniques; 1998 Mar; 24(3):432-7. PubMed ID: 9526654
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked.
    McGowan JE
    J Hosp Infect; 2004 Aug; 57(4):281-4. PubMed ID: 15320355
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant
    Fournier S; Desenfant L; Monteil C; Nion-Huang M; Richard C; Jarlier V;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486831
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Emerging extensively drug-resistant bacteria (eXDR) in France in 2018.
    Colomb-Cotinat M; Soing-Altrach S; Leon A; Savitch Y; Poujol I; Naas T; Cattoir V; Berger-Carbonne A; Dortet L;
    Med Mal Infect; 2020 Nov; 50(8):715-722. PubMed ID: 32113869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.